Associate Vice President Global Communications Cardiometabolic Health

Associate Vice President - Global Communications Cardiometabolic Health

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first.

We’re looking for people who are determined to make life better for people around the world.

Company Overview

Lilly CMH is a growth business driver at Eli Lilly and Company with important new treatments entering global markets. Our communications needs are evolving. Lilly has been committed to advancing care in this therapeutic area with innovative treatments. We must communicate in ways that are modern, innovative, and effective.

Lilly unites caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. Lilly is also committed to fostering a diverse and inclusive workforce.

We give our best effort to our work, and we re looking for people who are determined to support our work for the CMH community.

The AVP of Communications, Lilly CMH, will lead global communications strategy and support for key product areas in Lilly s CMH business. This role is accountable for globally setting the communications strategy for the therapeutic area and ensuring strong execution in key markets including the U.S. and IBU (International Business Unit). The AVP will work closely with teams across markets to drive consistent, impactful communications across geographies.

Oversight will include traditional and non-traditional communications supporting Lilly s broad and growing portfolio and pipeline of CMH medications. The position includes communications management of product launches, key data releases, critical consumer programs as well as partnering with Crisis and Issues team on key policy issues such as affordability and access.

The AVP will serve as a trusted member of the Therapeutic Area Business Leader s extended leadership team, providing strategic counsel and communications expertise to guide business decisions. This role requires executive presence, the ability to remain calm under pressure, and strong collaboration skills with the ability to work effectively across all organizational levels. The successful candidate will be open to new ways of thinking and will introduce innovative approaches given the highly consumer-centric nature of this space.

The position will report to Chief Communications Officer and lead a team of individuals. The leader will be accountable for leading an agile team of communications colleagues to effectively execute a global communications strategy that cuts across early stages to commercialization. The leader must approach the work with a "Team Lilly" mindset – i.e., supporting the CMH business while keeping other interests and stakeholders in mind.

Specific
Global
oversight responsibilities include

• Owns global external and internal communications for a therapeutic area, setting strategy and driving execution across U.S. and International markets.

• Set the global communications execution plan for the CMH therapeutic area and ensure strong execution across all markets.

• Provide governance and oversight with communications colleagues in US and IBU affiliates to ensure alignment, measurement, and execution excellence

• Lead Communications around key data and regulatory milestones for new pipeline assets as well as new indications and line extensions for best-in-class products

• Lead environment shaping communications efforts around scientific data, regulatory milestones, launches, and line extensions to help support strong launches of our new molecules integrated with…